107 related articles for article (PubMed ID: 20307614)
21. Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
Li L; Pang XB; Chen BN; Gao L; Wang L; Wang SB; Wang SB; Liu DP; Du GH
Biochem Biophys Res Commun; 2013 May; 435(1):69-75. PubMed ID: 23611777
[TBL] [Abstract][Full Text] [Related]
22. Src tyrosine kinase mediates endothelin-1-induced early growth response protein-1 expression via MAP kinase-dependent pathways in vascular smooth muscle cells.
Simo-Cheyou ER; Vardatsikos G; Srivastava AK
Int J Mol Med; 2016 Dec; 38(6):1879-1886. PubMed ID: 27748819
[TBL] [Abstract][Full Text] [Related]
23. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
Zahradka P; Litchie B; Storie B; Helwer G
Endocrinology; 2004 Jun; 145(6):2978-87. PubMed ID: 14976148
[TBL] [Abstract][Full Text] [Related]
24. Luteolin inhibited hydrogen peroxide-induced vascular smooth muscle cells proliferation and migration by suppressing the Src and Akt signalling pathways.
Lang Y; Chen D; Li D; Zhu M; Xu T; Zhang T; Qian W; Luo Y
J Pharm Pharmacol; 2012 Apr; 64(4):597-603. PubMed ID: 22420665
[TBL] [Abstract][Full Text] [Related]
25. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.
Godeny MD; Sayeski PP
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1308-17. PubMed ID: 16723511
[TBL] [Abstract][Full Text] [Related]
26. Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2.
Frank GD; Saito S; Motley ED; Sasaki T; Ohba M; Kuroki T; Inagami T; Eguchi S
Mol Endocrinol; 2002 Feb; 16(2):367-77. PubMed ID: 11818507
[TBL] [Abstract][Full Text] [Related]
27. Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways.
Kyotani Y; Zhao J; Tomita S; Nakayama H; Isosaki M; Uno M; Yoshizumi M
J Pharmacol Sci; 2010; 113(2):161-8. PubMed ID: 20508392
[TBL] [Abstract][Full Text] [Related]
28. The role of caveolin1 and sprouty1 in genistein's regulation of vascular smooth muscle cell and endothelial cell proliferation.
Xiang Q; Lin G; Xu J; Zheng S; Chen S; Zhou K; Wang T
Eur J Pharmacol; 2010 Dec; 648(1-3):153-61. PubMed ID: 20828553
[TBL] [Abstract][Full Text] [Related]
29. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells.
Ishida M; Ishida T; Thomas SM; Berk BC
Circ Res; 1998 Jan 9-23; 82(1):7-12. PubMed ID: 9440699
[TBL] [Abstract][Full Text] [Related]
30. Activation of Src protein tyrosine kinase plays an essential role in urocortin-mediated cardioprotection.
Yuan Z; McCauley R; Chen-Scarabelli C; Abounit K; Stephanou A; Barry SP; Knight R; Saravolatz SF; Saravolatz LD; Ulgen BO; Scarabelli GM; Faggian G; Mazzucco A; Saravolatz L; Scarabelli TM
Mol Cell Endocrinol; 2010 Aug; 325(1-2):1-7. PubMed ID: 20416357
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X
PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449
[TBL] [Abstract][Full Text] [Related]
32. Periodic mechanical stress enhances rat chondrocyte area expansion and migration through Src-PLCgamma1-ERK1/2 signaling.
Nong L; Yin G; Ren K; Tang J; Fan W
Eur J Cell Biol; 2010 Sep; 89(9):705-11. PubMed ID: 20537760
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells.
Liao DF; Monia B; Dean N; Berk BC
J Biol Chem; 1997 Mar; 272(10):6146-50. PubMed ID: 9045626
[TBL] [Abstract][Full Text] [Related]
34. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
[TBL] [Abstract][Full Text] [Related]
35. Position of Src tyrosine kinases in the interaction between angiotensin II and endothelin in in vivo vascular protein synthesis.
Beaucage P; Iglarz M; Servant M; Touyz RM; Moreau P
J Hypertens; 2005 Feb; 23(2):329-35. PubMed ID: 15662221
[TBL] [Abstract][Full Text] [Related]
36. Smooth muscle 22α facilitates angiotensin II-induced signaling and vascular contraction.
Xie XL; Nie X; Wu J; Zhang F; Zhao LL; Lin YL; Yin YJ; Liu H; Shu YN; Miao SB; Li H; Chen P; Han M
J Mol Med (Berl); 2015 May; 93(5):547-58. PubMed ID: 25515236
[TBL] [Abstract][Full Text] [Related]
37. Evidence for ERK1/2 activation by thrombin that is independent of EGFR transactivation.
Bobe R; Yin X; Roussanne MC; Stepien O; Polidano E; Faverdin C; Marche P
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H745-54. PubMed ID: 12730054
[TBL] [Abstract][Full Text] [Related]
38. ERK1/2 pathway is involved in the inhibitory effect of crocetin on angiotensin II-induced vascular smooth muscle cell proliferation.
Zhou CH; Qian ZY; Zheng SG; Xiang M
Eur J Pharmacol; 2006 Mar; 535(1-3):61-8. PubMed ID: 16580346
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Src family kinase activation in angiotensin II-induced hyperresponsiveness of rat bronchial smooth muscle.
Sakai H; Nishimura A; Watanabe Y; Nishizawa Y; Hashimoto Y; Chiba Y; Misawa M
Peptides; 2010 Dec; 31(12):2216-21. PubMed ID: 20863867
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C and Src family kinases mediate angiotensin II-induced protein kinase D activation and acute aldosterone production.
Olala LO; Shapiro BA; Merchen TC; Wynn JJ; Bollag WB
Mol Cell Endocrinol; 2014 Jul; 392(1-2):173-81. PubMed ID: 24859649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
